chloramphenicol has been researched along with Osteogenic Sarcoma in 1 studies
Amphenicol: Chloramphenicol and its derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteogenic sarcoma developed in a 14-year-old boy 13 years after he had partially recovered from chloramphenicol-induced aplastic anemia." | 3.65 | Osteogenic sarcoma in a patient with aplastic anemia. ( Eveloff, AR; Lascari, AD, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lascari, AD | 1 |
| Eveloff, AR | 1 |
1 other study available for chloramphenicol and Osteogenic Sarcoma
| Article | Year |
|---|---|
Osteogenic sarcoma in a patient with aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Bone Neoplasms; Chloramphenicol; Humans; Male; Methotrexate; Osteosarc | 1977 |